IDEXX LABORATORIES INC /DE IDXX
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1991-06-21
IDEXX LABORATORIES INC /DE institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 9,603,226 | $4.7B |
| Point72 Asset Management, L.P. | 129,284 | $72.6M |
| CITADEL ADVISORS LLC | 128,866 | $72.4M |
| MILLENNIUM MANAGEMENT LLC | 107,046 | $60.1M |
| AQR CAPITAL MANAGEMENT LLC | 96,726 | $53.8M |
| RENAISSANCE TECHNOLOGIES LLC | 48,504 | $27.3M |
| Bridgewater Associates, LP | 10,314 | $5.8M |
| D. E. Shaw & Co., Inc. | 1,074 | $603,470 |
Source: SEC EDGAR filings · CIK 0000874716 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.